Product Name

  • Name

    Topotecan

  • EINECS 231-595-7
  • CAS No. 123948-87-8
  • Article Data8
  • CAS DataBase
  • Density 1.49 g/cm3
  • Solubility soluble in water
  • Melting Point ?114 °C
  • Formula C23H23N3O5
  • Boiling Point 782.9 °C at 760 mmHg
  • Molecular Weight 421.453
  • Flash Point 427.3 °C
  • Transport Information UN 3286 3/PG 2
  • Appearance light yellow needle crystal or crystalline powder
  • Safety 26-45-36/37/39-37/39
  • Risk Codes 36/37/38-67-35-20-11-34
  • Molecular Structure Molecular Structure of 123948-87-8 (Topotecan)
  • Hazard Symbols ToxicT,CorrosiveC,FlammableF,IrritantXi
  • Synonyms 4-Ethyl-4,9-dihydroxy-10-[(dimethylamino)methyl]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;9-Dimethylaminomethyl-10-hydroxycamptothecin;(S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione;1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, (4S)-;
  • PSA 104.89000
  • LogP 1.84680

Synthetic route

formaldehyd
50-00-0

formaldehyd

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

dimethyl amine
124-40-3

dimethyl amine

topotecan
123948-87-8

topotecan

Conditions
ConditionsYield
With acetic acid Mannich reaction;65%
In acetic acid at 40 - 90℃; Mannich Aminomethylation;
dichloromethane
75-09-2

dichloromethane

(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

dimethyl amine
124-40-3

dimethyl amine

topotecan
123948-87-8

topotecan

Conditions
ConditionsYield
With potassium carbonate at 20℃; for 5h; Mannich reaction;65%
camptothecin
7689-03-4

camptothecin

topotecan
123948-87-8

topotecan

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: H2; AcOH / PtO2
1.2: 51 percent / Pb(OAc)4; AcOH
2.1: 65 percent / aq. AcOH
View Scheme
(S)-10-hydroxycamptothecin
19685-09-7

(S)-10-hydroxycamptothecin

N,N-dimethyl(methylene)ammonium chloride
30354-18-8

N,N-dimethyl(methylene)ammonium chloride

topotecan
123948-87-8

topotecan

Conditions
ConditionsYield
With triethylamine In dichloromethane; isopropyl alcohol at 20 - 35℃; for 12h; Mannich Reaction;
triethylsilyl chloride
994-30-9

triethylsilyl chloride

topotecan
123948-87-8

topotecan

20-OTES topotecan
1004511-35-6

20-OTES topotecan

Conditions
ConditionsYield
Stage #1: topotecan With 1H-imidazole In N,N-dimethyl-formamide for 0.166667h; Inert atmosphere;
Stage #2: triethylsilyl chloride With dmap In N,N-dimethyl-formamide
94%
With 1H-imidazole; dmap In N,N-dimethyl-formamide for 52.1667h;94%
topotecan
123948-87-8

topotecan

tert-butyl (2-isocyanatoethyl)carbamate
284049-22-5

tert-butyl (2-isocyanatoethyl)carbamate

(S)-tert-butyl (10-((dimethylamino)methyl)-4-ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl) ethane-1,2-diyldicarbamate

(S)-tert-butyl (10-((dimethylamino)methyl)-4-ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl) ethane-1,2-diyldicarbamate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide; acetonitrile at 0 - 20℃; for 2h;69%
topotecan
123948-87-8

topotecan

tert-butyl 2-isocyanatoacetate
113238-61-2

tert-butyl 2-isocyanatoacetate

(S)-tert-butyl 2-((((10-((dimethylamino)methyl)-4-ethyl-4- hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl)oxy)carbonyl)amino)acetate

(S)-tert-butyl 2-((((10-((dimethylamino)methyl)-4-ethyl-4- hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl)oxy)carbonyl)amino)acetate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide; acetonitrile at 0 - 20℃; for 2h;68%
topotecan
123948-87-8

topotecan

[11C]methyl triflate
145577-00-0

[11C]methyl triflate

9-[([11C]trimethylammonium)methyl]-10-hydroxy-20(S)-camptothecin triflate

9-[([11C]trimethylammonium)methyl]-10-hydroxy-20(S)-camptothecin triflate

Conditions
ConditionsYield
In acetonitrile60%
In acetonitrile at -15 - 80℃;
topotecan
123948-87-8

topotecan

Topotecan hydroxyl acid

Topotecan hydroxyl acid

Conditions
ConditionsYield
With phosphate buffer Ambient temperature; other camptothecin lactone; also in the presence of DNA oligonucleotides; rate of hydrolysis;
With poly(DL-lactide-co-glycolide); poly(vinyl alcohol) In various solvents at 37℃; for 192h; pH=7.4; Product distribution; Kinetics; Further Variations:; reaction times; Hydrolysis;
With water at 37℃;
topotecan
123948-87-8

topotecan

Topotecan hydrochloride
119413-54-6, 123949-07-5

Topotecan hydrochloride

Conditions
ConditionsYield
With hydrogenchloride In methanol; water at 10 - 30℃; for 2h; Product distribution / selectivity;
topotecan
123948-87-8

topotecan

methyl trifluoromethanesulfonate
333-27-7

methyl trifluoromethanesulfonate

A

9-[(trimethylammonium)methyl]-10-hydroxy-20(S)-camptothecin triflate

9-[(trimethylammonium)methyl]-10-hydroxy-20(S)-camptothecin triflate

B

C21H18N2O6
175613-38-4

C21H18N2O6

C

CHF3O3S*C23H23N3O5
1243272-93-6

CHF3O3S*C23H23N3O5

D

CF3O3S(1-)*C25H28N3O5(1+)

CF3O3S(1-)*C25H28N3O5(1+)

Conditions
ConditionsYield
Stage #1: methyl trifluoromethanesulfonate With potassium carbonate In dichloromethane for 0.5h;
Stage #2: topotecan In dichloromethane at 20℃; for 24h;
Methyl methanesulfonate
66-27-3

Methyl methanesulfonate

topotecan
123948-87-8

topotecan

A

C21H18N2O6
175613-38-4

C21H18N2O6

B

CH4O3S*C23H23N3O5

CH4O3S*C23H23N3O5

C

CH3O3S(1-)*C25H28N3O5(1+)

CH3O3S(1-)*C25H28N3O5(1+)

D

10-hydroxy-9-<(trimethylammonio)methyl>-(20S)-camptothecin methanosulfonate
123948-98-1

10-hydroxy-9-<(trimethylammonio)methyl>-(20S)-camptothecin methanosulfonate

Conditions
ConditionsYield
Stage #1: Methyl methanesulfonate With potassium carbonate In dichloromethane for 0.5h;
Stage #2: topotecan In dichloromethane at 20℃; for 24h;
topotecan
123948-87-8

topotecan

25,26,27,28-terahydroxycalix[4]arene-5,11,7,23-tetrasulfonic acid
386768-13-4, 189397-70-4, 112269-92-8

25,26,27,28-terahydroxycalix[4]arene-5,11,7,23-tetrasulfonic acid

C23H23N3O5*C28H24O16S4

C23H23N3O5*C28H24O16S4

Conditions
ConditionsYield
In methanol; water at 20℃; for 48h;
topotecan
123948-87-8

topotecan

topotecan lactam

topotecan lactam

Conditions
ConditionsYield
Stage #1: topotecan With isopropylamine
Stage #2: With pyridine; acetic anhydride
Stage #3: With ammonia In dichloromethane
Stage #1: topotecan With isopropylamine
Stage #2: With pyridine; acetic anhydride
Stage #3: With ammonia In dichloromethane
topotecan
123948-87-8

topotecan

C26H28N4O6

C26H28N4O6

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: dmap; dicyclohexyl-carbodiimide / dichloromethane / 66 h / 20 °C
2: trifluoroacetic acid / dichloromethane / 1 h / 20 °C
View Scheme
topotecan
123948-87-8

topotecan

(S)-7-((10-((dimethylamino)methyl)-4-ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl)oxy)heptanoic acid

(S)-7-((10-((dimethylamino)methyl)-4-ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl)oxy)heptanoic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: potassium carbonate / N,N-dimethyl-formamide / 24 h / Heating
2: lithium hydroxide; water / tetrahydrofuran / 6 h / 20 °C
View Scheme
topotecan
123948-87-8

topotecan

(S)-7-((10-((dimethylamino)methyl)-4-ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl)oxy)-N-(5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)heptanamide

(S)-7-((10-((dimethylamino)methyl)-4-ethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl)oxy)-N-(5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl)heptanamide

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: potassium carbonate / N,N-dimethyl-formamide / 24 h / Heating
2: lithium hydroxide; water / tetrahydrofuran / 6 h / 20 °C
3: 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphinane-2,4,6-trioxide; triethylamine / N,N-dimethyl-formamide / 0 - 20 °C / Inert atmosphere
View Scheme
succinic acid anhydride
108-30-5

succinic acid anhydride

topotecan
123948-87-8

topotecan

9-dimethylaminomethyl-hydroxycamptothecin-10-succinic acid

9-dimethylaminomethyl-hydroxycamptothecin-10-succinic acid

Conditions
ConditionsYield
With pyridine at 50℃; for 48h;0.35 g
topotecan
123948-87-8

topotecan

C62H70N7O20P

C62H70N7O20P

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: pyridine / 48 h / 50 °C
2: 1,1'-carbonyldiimidazole; 1,8-diazabicyclo[5.4.0]undec-7-ene / dimethyl sulfoxide / 24 h / 20 °C
View Scheme

Topotecan Specification

1. Introduction of Topotecan

The Topotecane with CAS registry number of 123948-87-8, has the systematic name is (4S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione. It belongs to product categories of APIs. This chemical is a light yellow needle crystal or crystalline powder and it can be used as anti-cancer drugs.

2. Properties of Topotecan

Physical properties about Topotecane are: (1)ACD/LogP: 1.08; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -1.06; (4)ACD/LogD (pH 7.4): 0.45; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 1; (8)ACD/KOC (pH 7.4): 21.36; (9)#H bond acceptors: 8; (10)#H bond donors: 2; (11)#Freely Rotating Bonds: 5; (12)Polar Surface Area: 81.2Å2; (13)Index of Refraction: 1.733; (14)Molar Refractivity: 112.73 cm3; (15)Molar Volume: 281.3 cm3; (16)Polarizability: 44.69×10-24cm3; (17)Surface Tension: 82.8 dyne/cm; (18)Density: 1.49 g/cm3; (19)Flash Point: 427.3 °C; (20)Enthalpy of Vaporization: 119.49 kJ/mol; (21)Boiling Point: 782.9 °C at 760 mmHg; (22)Vapour Pressure: 8.13E-26 mmHg at 25 °C

3. Structure Descriptors of Topotecan

You could convert the following datas into the molecular structure:
1). Canonical SMILES: CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=C(C5=C4)CN(C)C)O)O
2). Isomeric SMILES: CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=C(C5=C4)CN(C)C)O)O
3). InChI: InChI=1S/C23H23N3O5/c1-4-23(30)16-8-18-20-12(9-26(18)21(28)15(16)11-31-22(23)29)7-13-14(10-25(2)3)19(27)6-5-17(13)24-20/h5-8,27,30H,4,9-11H2,1-3H3/t23-/m0/s1
4). InChIKey: UCFGDBYHRUNTLO-QHCPKHFHSA-N

4. Preparation of Topotecan

Preparation of Topotecane: it is prepared by reaction of 37% formaldehyde with 40% dimethylamine. Besides, The reaction needs reagent acetic acid.

Topotecan hydrochloride is prepared by reaction of 37% formaldehyde with 40% dimethylamine.

5. Safety Information of Topotecan

When you are using this chemical, please be cautious about it. As a chemical, it is irritating to eyes, respiratory system and skin. Besides, it has highly flammable and may causes severe burns. What's more, it is harmful by inhalation. During using it, wear suitable protective clothing, gloves and eye/face protection. In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. If you feel unwell or accident happens seek medical advice immediately.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View